USFDA completes inspections at Alkem Laboratories’ two facilities

26 Aug 2019 Evaluate

US Food and Drug Administration (USFDA) has completed inspections at Alkem Laboratories’ two manufacturing facilities. The agency has conducted inspection at St. Louis, USA from August 16, 2019 to August 22, 2019 and Baddi, India from August 19, 2019 to August 23, 2019.

At the end of the inspection, the company has received a Form 483 with four observations for the facility located at St. Louis and no Form 483 is received for the facility located at Baddi.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

4779.00 67.10 (1.42%)
25-Apr-2024 12:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1503.25
Dr. Reddys Lab 6001.75
Cipla 1395.15
Zydus Lifesciences 930.85
Lupin 1593.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.